You are here:
Publication details
The Outcome of Unselected Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Treated with Imatinib In the First Line and the Prognostic Value of ELN Defined Responses-Population Based Analysis of 458 Patients Treated Between 2003-2009.
Authors | |
---|---|
Year of publication | 2010 |
Type | Conference abstract |
MU Faculty or unit | |
Citation |